Alimera Sciences Inc. Shares Close the Day 10.3% Higher - Daily Wrap
The company saw its shares close the day 10.3% higher than yesterday, with trading volume lower than its 30 day average.
Dec 25, 2021 by Kwhen Finance Editors
Alimera Sciences Inc. (ALIM) shares closed today 10.3% higher than it did at the end of yesterday. The stock is currently up 29.1% year-to-date, up 16.5% over the past 12 months, and down 67.6% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%.
Trading Activity
- Shares traded as high as $5.62 and as low as $4.30 this week.
- Shares closed 55.5% below its 52-week high and 38.3% above its 52-week low.
- Trading volume this week was 61.9% higher than the 10-day average and 46.6% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Alimera Sciences Inc. | 10.3 | 29.1 | 16.5 | -59.0 | 27.4 |
| Dow Jones Industrial Average | 0.6 | 19.5 | 21.3 | -1.6 | 22.0 |
| S&P 500 Index | 0.6 | 27.5 | 29.7 | -0.7 | 30.2 |
| Health Care | 0.5 | 22.4 | 24.2 | -0.3 | 26.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -488.0%
- The company's stock price performance over the past 12 months beats the peer average by -243.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Alimera Sciences Inc. | ALIM | 0 | 29.1 | 16.5 | -59.0 | 27.4 |
| Peer Avg | N/A | -0.3 | -7.5 | -11.5 | -36.2 | 26.1 |
| Regeneron Pharmaceuticals, Inc. | REGN | 9.5 | 29.4 | 27.1 | -9.8 | 40.5 |
| Insmed Inc | INSM | -7.9 | -15.0 | -20.2 | -37.5 | 29.1 |
| Aerie Pharmaceuticals Inc | AERI | -2.4 | -36.9 | -41.2 | -61.5 | 8.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: